Andrea K. Kerrigan, FDA outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
|Articles|November 20, 2019
- Pharmaceutical Technology\'s In the Lab eNewsletter-12-04-2019
- Volume 14
- Issue 12
Definer DF2000 Knife Mill from Franklin Miller Offers Ease of Use
The device focuses on ease of maintenance and reliability while cutting materials to desired output size without overgrinding or excessive heat build-up.
Advertisement
The Definer DF2000 knife mill from Franklin Miller focuses on ease of maintenance and reliability while cutting materials to desired output size without overgrinding or excessive heat build-up. The company introduced the product on Nov. 14, 2019.
The device’s rotor design comes equipped with replaceable rotary knife elements and several cutter elements and screen sizes that allow for the customization of the condition, mill, and deagglomerate of the device. The stainless-steel hopper and protective flaps help to keep work environments clean, while the rotational speed, particle size, and throughput are maintained with the knife mill’s variable speed controller. Additional add-ons are also available and include casters with lockable wheels and a pneumatic discharge system.
Source:
Articles in this issue
almost 7 years ago
Detecting Residual Moisture in Lyophilized Productalmost 7 years ago
Overview of the Fundamentals in Developing a Bioassayalmost 7 years ago
Steriline’s Robotic Nest Filling Machine Enhances Drug R&Dalmost 7 years ago
Recipharm Expands Indian Injectable Dosage Form Capabilitiesalmost 7 years ago
MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotecalmost 7 years ago
Vac-U-Max Names 2019 a Banner Year for Company Milestonesalmost 7 years ago
Gemini, BelHealth Acquire Orflo Technologiesalmost 7 years ago
Catalent Introduces New Next-Generation Cell-Line Development Technologyalmost 7 years ago
Intertek Increases Biopharmaceutical Services FacilityAdvertisement
Related to this article
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Advertisement
Advertisement